Atlas Trials

Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)

Clinical trial NCT04170556 · COMPLETED

Trial details

NCT number
NCT04170556
Sponsor
Fundacion Clinic per a la Recerca Biomédica
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2020-03-16
Primary completion
2024-07-09
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.